Investors bought shares of Anthem Inc (NYSE:ANTM) on weakness during trading hours on Monday following insider selling activity. $132.05 million flowed into the stock on the tick-up and $87.01 million flowed out of the stock on the tick-down, for a money net flow of $45.04 million into the stock. Of all companies tracked, Anthem had the 13th highest net in-flow for the day. Anthem traded down ($2.94) for the day and closed at $229.86Specifically, CFO John E. Gallina sold 24,576 shares of the stock in a transaction dated Monday, March 5th. The stock was sold at an average price of $229.81, for a total transaction of $5,647,810.56. Following the completion of the sale, the chief financial officer now directly owns 22,139 shares in the company, valued at approximately $5,087,763.59. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Gloria M. Mccarthy sold 14,429 shares of the stock in a transaction dated Thursday, January 4th. The shares were sold at an average price of $229.68, for a total value of $3,314,052.72. Following the sale, the executive vice president now owns 30,667 shares of the company’s stock, valued at $7,043,596.56. The disclosure for this sale can be found here. Insiders have sold a total of 200,720 shares of company stock worth $47,512,932 over the last quarter. Corporate insiders own 0.36% of the company’s stock.
Several equities research analysts recently weighed in on ANTM shares. Royal Bank of Canada restated a “buy” rating on shares of Anthem in a report on Thursday, January 4th. ValuEngine upgraded Anthem from a “hold” rating to a “buy” rating in a report on Sunday, December 31st. Bank of America increased their target price on Anthem from $249.00 to $254.00 and gave the company a “buy” rating in a report on Friday, November 17th. Credit Suisse Group restated an “outperform” rating and set a $280.00 target price (up from $255.00) on shares of Anthem in a report on Thursday, February 1st. Finally, Jefferies Group upgraded Anthem from a “hold” rating to a “buy” rating and dropped their target price for the company from $235.00 to $211.00 in a report on Friday, January 12th. Four research analysts have rated the stock with a hold rating and seventeen have given a buy rating to the stock. The company has an average rating of “Buy” and a consensus price target of $233.25.
The company has a quick ratio of 1.55, a current ratio of 1.55 and a debt-to-equity ratio of 0.66. The firm has a market cap of $58,870.00, a price-to-earnings ratio of 22.66, a price-to-earnings-growth ratio of 1.34 and a beta of 0.87.
Anthem (NYSE:ANTM) last released its quarterly earnings data on Wednesday, January 31st. The company reported $1.29 earnings per share for the quarter, topping the consensus estimate of $1.25 by $0.04. Anthem had a return on equity of 12.29% and a net margin of 4.27%. The business had revenue of $22.45 billion during the quarter, compared to analysts’ expectations of $22.17 billion. During the same quarter last year, the business posted $1.76 EPS. The business’s revenue was up 4.5% on a year-over-year basis. research analysts anticipate that Anthem Inc will post 15.09 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, March 23rd. Shareholders of record on Friday, March 9th will be issued a $0.75 dividend. The ex-dividend date is Thursday, March 8th. This represents a $3.00 annualized dividend and a yield of 1.30%. This is a boost from Anthem’s previous quarterly dividend of $0.70. Anthem’s dividend payout ratio (DPR) is 29.53%.
Anthem announced that its board has authorized a stock repurchase program on Thursday, December 7th that allows the company to repurchase $5.00 billion in shares. This repurchase authorization allows the company to reacquire shares of its stock through open market purchases. Stock repurchase programs are often an indication that the company’s board believes its stock is undervalued.
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in ANTM. FineMark National Bank & Trust lifted its stake in shares of Anthem by 8.3% in the 4th quarter. FineMark National Bank & Trust now owns 2,933 shares of the company’s stock valued at $660,000 after purchasing an additional 225 shares during the period. Ladenburg Thalmann Financial Services Inc. lifted its stake in shares of Anthem by 2.8% in the 4th quarter. Ladenburg Thalmann Financial Services Inc. now owns 8,451 shares of the company’s stock valued at $1,903,000 after purchasing an additional 232 shares during the period. Dowling & Yahnke LLC lifted its stake in shares of Anthem by 3.3% in the 4th quarter. Dowling & Yahnke LLC now owns 7,445 shares of the company’s stock valued at $1,675,000 after purchasing an additional 241 shares during the period. Commerce Bank lifted its stake in shares of Anthem by 2.0% in the 3rd quarter. Commerce Bank now owns 12,330 shares of the company’s stock valued at $2,341,000 after purchasing an additional 242 shares during the period. Finally, Reliance Trust Co. of Delaware lifted its stake in shares of Anthem by 4.7% in the 4th quarter. Reliance Trust Co. of Delaware now owns 5,678 shares of the company’s stock valued at $1,278,000 after purchasing an additional 255 shares during the period. Institutional investors and hedge funds own 88.33% of the company’s stock.
TRADEMARK VIOLATION NOTICE: This piece of content was originally posted by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are viewing this piece of content on another domain, it was stolen and reposted in violation of U.S. & international copyright & trademark laws. The correct version of this piece of content can be accessed at https://ledgergazette.com/2018/03/14/traders-buy-anthem-antm-on-weakness-following-insider-selling.html.
Anthem Company Profile
Anthem, Inc is a health benefits company. The Company operates through three segments: Commercial and Specialty Business, Government Business and Other. It offers a spectrum of network-based managed care plans to large and small employer, individual, Medicaid and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; indemnity plans and other hybrid plans, including consumer-driven health plans; and hospital only and limited benefit products.
Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.